
Prescriber Education & B2B Marketing
For Schedule 8 medicinal cannabis products, your revenue does not flow from consumers, it flows from Authorised Prescribers. Clinicians who understand your product, trust your brand, and feel confident recommending it to appropriate patients. We design highly specialised B2B marketing campaigns, clinical education assets, and peer-to-peer outreach strategies that build prescriber awareness, trust, and dispensing volume across Australia's regulated prescriber network.
How We Grow Your Prescriber Network
Prescriber Identification & Mapping
We identify and segment the Authorised Prescribers and GP networks most relevant to your product's approved indications, geographic reach, and patient demographics. This precision means your outreach budget is focused entirely on clinicians with both the authority and the patient profile to generate dispensing volume.
Clinical Education Assets
Prescribers do not respond to marketing — they respond to evidence. We develop clinical education materials including product monographs, indication summaries, dosing guides, and continuing professional development content that communicates your product's profile in the language clinicians trust. All assets are reviewed against TGA and AHPRA guidelines before distribution.
B2B Outreach Campaigns
We design and execute multi-channel outreach campaigns targeting prescriber audiences through compliant digital channels, medical education platforms, and peer networks. Every campaign is structured to inform rather than promote, positioning your brand as a clinical resource rather than an advertiser — which is both the compliant approach and, in practice, the most effective one.
Dispensing Volume Tracking
We build reporting systems that connect your prescriber outreach activity to real dispensing outcomes. You see which education touchpoints, which prescriber segments, and which geographic regions are converting into sustained dispensing volume — giving you the data to continuously refine your B2B strategy and allocate resources where they generate the highest clinical and commercial return.